CBS 2019
CBSMD教育中心
中 文

急性冠脉综合征

Abstract

Recommended Article

Impact of tissue protrusion after coronary stenting in patients with ST-segment elevation myocardial infarction A Novel Circulating MicroRNA for the Detection of Acute Myocarditis Antiplatelet therapy in patients with myocardial infarction without obstructive coronary artery disease The (R)Evolution of the CICU - Better for the Patient, Better for Education Myocardial Infarction Risk Stratification With a Single Measurement of High-Sensitivity Troponin I Nonculprit Lesion Myocardial Infarction Following Percutaneous Coronary Intervention in Patients With Acute Coronary Syndrome Management of Myocardial Revascularization Failure: An Expert Consensus Document of the EAPCI Open sesame technique in percutaneous coronary intervention for ST-elevation myocardial infarction

Clinical Trial2018 Jun;200:17-23.

JOURNAL:Am J Cardiol. Article Link

An open-Label, 2 × 2 factorial, randomized controlled trial to evaluate the safety of apixaban vs. vitamin K antagonist and aspirin vs. placebo in patients with atrial fibrillation and acute coronary syndrome and/or percutaneous coronary intervention: Rationale and design of the AUGUSTUS trial

Lopes RD, Vora AN, Liaw D et al. Keywords: apixaban; vitamin K antagonist; aspirin; placebo; ACS; PCI;

FULL TEXT PDF